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Asthma is a hereditary disease associated with IgE-mediated reaction. Whether maternal atopy and paternal atopy have diﬀerent
impacts on perinatal IgE production and asthma development remains unclear. This paper reviews and summarizes the eﬀects of
maternal and paternal atopy on the developmental aspects of IgE production and asthma. Maternal atopy aﬀects both pre- and
postnatal IgE production, whereas paternal atopy mainly aﬀects the latter. Maternally transmitted genes GSTP1 and FceRI-beta
are associated with lung function and allergic sensitization, respectively. In IgE production and asthma development, the maternal
inﬂuence on gene-environment interaction is greater than paternal inﬂuence. Maternal, paternal, and/or postnatal environmental
modulation of allergic responses have been linked to epigenetic mechanisms, which may be good targets for early prevention of
asthma.
1.Introduction
Theprevalenceofasthmahasdramaticallyincreasedoverthe
past few decades, particularly in children [1]. Most child-
hood allergic diseases, such as atopic dermatitis and asthma,
develop in the ﬁrst few years of life [2, 3]. Understanding the
developmental process of allergic diseases, which have long
beenattributedtoIgE-mediatedmechanisms[4,5]andiden-
tifying factors that play important roles in perinatal IgE pro-
duction and asthma development may help early predict and
prevent the occurrence of allergic diseases. Evidence has
shown that allergy sensitization may occur in fetal life [6, 7],
and a number of factors have been shown to aﬀect the de-
velopment of allergic disease; family history of atopy, enviro-
nmental exposure in urban areas, maternal nutritional status
and stress during pregnancy, and the time and method of
complementary food initiation are all potential factors that
contribute to asthma. In addition, genetic polymorphisms
originating in maternal or paternal inheritance have been
implicated in IgE production and asthma development. This
paper reviews and addresses the diﬀerence between paternal
and maternal inheritance and environment in IgE produc-
tion and asthma development.
2. Associationof AntenatalIgE Production
with Asthma
An increase in blood IgE levels has long been implicated in
the development and severity of asthma [8, 9]. IgE produc-
tion and allergy sensitization are both active processes in the
prenatal and perinatal periods and are potentially inﬂuenc-
ed by genetic factors and the intrauterine and postnatal
environments. Antenatal allergy sensitization with IgE pro-
duction, reﬂected by the elevation of cord blood serum IgE
(CBIgE), has been studied as a predictor of asthma and other
IgE-mediated allergic diseases; however, the results are con-
troversial (Table 1). Some studies indicate that higher CBIgE
levels correlate with the development of aeroallergen sen-
sitization [10–12], recurrent wheezing in childhood [13],2 Clinical and Developmental Immunology
Table 1: Does CBIgE elevation predict allergy?
Parameters Population studied, country Reference
Parameters correlated with elevated CBIgE
Skin-prick test at age 4yr 1456, England [10]
Allergic sensitization and recurrent wheezing at age 7yr 380 high-risk newborns, Canada [13]
Allergic sensitization at 4 and 10yr and asthma at 10yr 1456, USA [14]
Skin-prick test at age 5yr, allergic rhinoconjunctivitis at age 20yr, and total IgE
at ages 11 and 20yr 200, Finland [15]
High IgE and allergic sensitization between the ages of 18 and 24 months 1884, Sweden [11]
Total IgE and allergic diseases before 5 years of age 1884, USA [12]
Parameters not correlated with elevated CBIgE
No signiﬁcant association with recurrent wheezing 1314, Germany [16]
Not better than family history to predict infant atopy 2814, USA [17]
Family history of atopy far more sensitive than CBIgE 1111, UK [18]
later development of childhood asthma [14], and allergic
rhinoconjunctivitis in adulthood [15]. However, other stud-
ies yielded discouraging results indicating that CBIgE eleva-
tion lacks the sensitivity for predicting the development of
allergic diseases in childhood [16–18]. The inconsistencies
may be due to diﬀerences in ethics, cut-oﬀ values of CBIgE
levels, and deﬁnitions of allergic diseases in these cohorts.
H o w e v e r ,ar e c e n ts t u d yf o u n ds t r o n ge v i d e n c et h a tm a t e r -
nal-fetaltransfermaybeacommoncauseofincreasedCBIgE
levels, especially in newborns with elevated cord blood
IgA levels [19] or allergen-speciﬁc IgE [20], which is not
commonly found in the cord blood of newborns, suggesting
maternal-fetal transfer of IgE or contamination of maternal
blood. As shown in Table 1, several studies have shown a cor-
relation between elevated CBIgE levels and allergic sensi-
tization and/or asthma, whereas other studies revealed no
correlation [10–18].
To determine whether prenatal IgE production reﬂects
CBIgE elevation and the development of allergic diseases,
we followed up a birth cohort of 230 newborns from the
prenatal stage to 6 months, 18 months, 3 years, and 6 years
of age. With CBIgE levels ≥0.5kU/L considered elevated, our
preliminary analysis of the total IgE levels in the 230 new-
borns who completed the followup revealed that newborns
with elevated CBIgE (0.5kU/L) exhibited a signiﬁcantly
higher risk of atopic dermatitis (odds ratio (OR), 2.067; 95%
conﬁdence interval (CI), 1.392–3.071) and allergic rhinitis
(OR, 1.840; 95% CI, 1.212–2.791), but not asthma, at 6 years
of age. The sensitivity and speciﬁcity of elevated CBIgE
(0.5kU/L)forpredictingatopicdermatitisandallergicrhini-
tiswere28.5%and83.8%and23.9%and85.3%,respectively.
Elevated CBIgE (0.5kU/L) was also highly correlated with
elevated IgE levels at 6 years of age (150kU/L) (OR, 2.671;
95% CI, 1.424–5.010); however, it exhibited poor sensitivity
(35%)buthighspeciﬁcity(83.2%).ThisindicatesthatCBIgE
levels are related to the development of allergic diseases and
that the CBIgE prediction of allergic outcomes during child-
hood may be speciﬁc but not sensitive enough for clinical
application. Other factors, such as elevated umbilical cord
blood CCL17 levels [21], CCL22 levels [22], or reduced IFN-
γ levels with enhanced IL-4-producing CD4+ cord blood T
cells [23], have been shown to be associated with atopic der-
matitis in infancy. Cord blood 25-hydroxyvitamin D levels
are inversely associated with the risk of childhood wheezing
[24]. More studies on the CBIgE levels and/or other chemo-
kine or cytokine levels of cord blood are needed to improve
their prediction value for childhood allergic diseases.
3. Different Implications of Paternal
and Maternal Atopy for IgE Production
andAsthma
The eﬀect of maternal total IgE levels or atopy on cord blood
IgE levels has been well recognized [25–30]; on the other
hand, paternal total IgE levels and paternal atopy have little
eﬀect on antenatal IgE production or early atopy [25–29].
However, paternal total IgE level, like maternal total IgE
levels, highly correlate with total IgE levels in children of
preschool age [31]. In other words, maternal total IgE levels
or sensitization may positively correlate with antenatal and
postnatal IgE production; however, paternal total IgE levels
or sensitization has little eﬀect on antenatal IgE production
but has a signiﬁcant impact on the IgE production at
preschool age (around 4–6 years). However, some studies
have shown a poor association between parental atopy and
atopic dermatitis in children up to 4 years of age [32, 33].
Although both maternal and paternal histories of asthma
are associated with childhood asthma, various studies have
shown that maternal history of asthma or atopy is one of
the most important risk factors for childhood asthma [34–
37] and is associated with increasing risk of admission for
childhood asthma [38]. A 2-stage case-control study in
Canada revealed that children born to asthmatic mothers are
at a higher risk of developing asthma than children born to
nonasthmatic mothers are (32.6% and 14.1%, resp.) [39].
Furthermore,paternalasthmais asigniﬁcant andstrongpre-
dictorofasthmaorairwayhyperresponsivenessinschool-ageClinical and Developmental Immunology 3
Table 2: Eﬀect of parental background on IgE production and asthma development.
Maternal background Paternal background
Gene
Maternal antioxidant gene polymorphisms: GSTP1 [51] GSTM1 and
GSTT1 [52]
Polymorphism of the beta-chain of high-aﬃnity IgE receptor (FceRI-beta)
[53], and 11q13 allele [54]
An allele at chromosome 7p [50]
Environment
Maternal asthma [34–39]
Fetal exposure to tobacco smoke, household allergens, and latex and/or
biocides [58–63, 65]
Fetal exposure to traﬃc air pollution [64]
Maternal prenatal exposure to farm, farm animals, and cat or dog
[58, 66, 68]
Mediterranean diet, ﬁsh intake, fatty acid status, and folic acid supplements
during pregnancy [24, 69, 72, 73]
Paternal asthma [40–43]
Paternal occupational ﬂour dust
exposure [65]
children [40–42]. In a study on asthma in consanguineous
families,paternalasthmaincreasedtheriskofasthmainboth
boys and girls (P = 0.021 for boys, P<0.001 for girls),
whereas maternal asthma had no signiﬁcant impact on
asthma in the oﬀspring [43]. These results indicate that the
eﬀect of maternal atopy on IgE production and allergic dis-
eases of the oﬀspring begins at the fetal stage and continues
to infancy and childhood; however, the impact of paternal
atopy is not apparent until childhood.
Accumulated evidence has also shown that maternal
asthma history has a greater impact on the subsequent de-
velopment of allergic asthma in the oﬀspring than paternal
asthma history has. In a meta-analysis of 33 studies from
1966 to 2009 investigating the impact of maternal asthma
and paternal asthma on the asthma of their oﬀspring, the OR
forasthmainchildrenofasthmaticmotherswassigniﬁcantly
higher than that in children of nonasthmatic mothers (3.04;
95% CI, 2.59–3.56). The corresponding OR for asthma in
children of asthmatic fathers only increased to 2.44 (2.14–
2.79). When comparing the OR, maternal asthma conferred
a greater risk of the disease than paternal asthma did (3.04
versus 2.44, P = 0.037) [44]. However, some studies have
shown that maternal and paternal airway hyperresponsive-
ness (AHR) or asthma increases the risk of AHR or asthma
in their oﬀspring [45, 46]. The opposite was observed by
Kurzius-Spencer and colleagues, who showed a strong
father-oﬀspring (particularly father-son), but not mother-
oﬀspring, correlation in airway responsiveness among chil-
dren [47]. Dold and colleagues have also shown that paternal
asthma history has a much greater impact, with a relative
risk of 4.4, than maternal asthma history has, with a 1.5-
fold risk of the occurrence of wheezy bronchitis in children
between the ages of 9 and 11 [48]. Similarly, in a study of
1,041 asthmatic children, Raby and his colleagues found that
children with a paternal history of asthma, but not with
a maternal history of asthma, showed signiﬁcantly greater
AHR than those without such history did [49]. Another
studybyLitonjuaandcolleagues[37]alsoshowedthatpater-
nal contributions to the risk of childhood asthma have a
greater inﬂuence on older children. These results suggest
thatAHRandasthmaareindependentlyinherited.Paternally
derived and maternally derived asthma modulate diﬀerent
gene expression pathways or epigenetic mechanisms to
transmit diﬀerent phenotypes (AHR and asthma) in the
oﬀspring.
In our birth cohort study, we analyzed whether the pre-
sence of paternal or maternal atopy, as deﬁned by total IgE>
150kU/L [26], inﬂuenced IgE production from the newborn
stage to 6 months, 18 months, 3 years, and 6 years of age. As
shown in Figure 1, maternal atopy, but not paternal atopy,
signiﬁcantly aﬀected antenatal IgE production, as reﬂected
by CBIgE elevation (Figures 1(a) and 1(c)). Maternal atopy
wassigniﬁcantlyassociatedwiththelog-transformedIgElev-
elsat6months,18months,3years,and6yearsofage,where-
as paternal atopy was only signiﬁcantly correlated with
log-transformed IgE levels at 3 years and 6 years of age
(Figures 1(b) and 1(d)). These results strongly indicate that
maternal inﬂuence on IgE production is exerted from the
antenatal stage through childhood, whereas paternal inﬂu-
ence on IgE production begins from early childhood and
increases with increasing age.
4. Effects of PaternalandMaternal
InheritanceandEnvironmenton IgE
Production and Asthma
Advances in the identiﬁcation of asthma-susceptibility genes
may provide some insights into the molecular mechanisms
underlying maternal and paternal inﬂuence on childhood
asthma. As shown in Table 2, Leaves and colleagues showed
thataregionofchromosome7p,restrictedtosiblingssharing
alleles inherited from fathers, not from mothers, is tightly
linked with AHR in an Australian population, suggesting
paternallyderivedallelesatthislocusmightaﬀectairwayres-
ponsiveness [50]. Maternal antioxidant gene polymorphisms
(GSTP1 and GSTM1, GSTT1)h a v eb e e nr e g a r d e da ss p e c i ﬁ c
risk factors for asthma in the oﬀspring and may modify the
relationship between prenatal acetaminophen exposure and
childhood asthma [51, 52]. Traherne and colleagues have
shown that the polymorphism of the high-aﬃnity IgE recep-
tor beta-chain (FceRI-beta) has a strong association with
positive allergy skin-prick tests and greater allergen-speciﬁc
IgE levels when these polymorphisms are inherited from the
mothers [53]. Cookson and his colleagues found that the
transmission of atopy at the chromosome 11q13 allele is4 Clinical and Developmental Immunology
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Figure 1: Diﬀerent implications of maternal and paternal IgE levels for antenatal IgE level and postnatal IgE production at diﬀerent ages
in our cohort study. (a), (c): Maternal (Ma) atopy, deﬁned as IgE > 150kU/L, but not paternal (Pa) atopy, signiﬁcantly aﬀected antenatal
IgE production, reﬂected by CBIgE elevation (>0.5kU/L). (b), (d): Maternal atopy (solid circles) was signiﬁcantly associated with log-trans-
formed IgE levels at 6 months (6m), 18 months (18m), 3 years (36m), and 6 years (6y) of age, whereas paternal atopy (open circles) was
only signiﬁcantly associated with log-transformed levels at 3 and 6 years of age.
detectableonlythroughthematernalline[54].Theseparent-
derived alleles associated with IgE production and asthma
provide insights into the impact of gender on the inheritance
of IgE production and the development of asthma.
Thereareseveralpossiblereasonstoexplainwhymothers
and fathers have diﬀerent impacts on IgE production and
asthma development in their oﬀspring, including exclusive
exposure to maternal environmental factors during fetal de-
velopment, fetomaternal-shared perinatal environmental ex-
posures (including breastfeeding), diﬀerent hormones, and
distinct genetic imprinting [49]. Moreover, certain genetic
alleles may have sex-speciﬁc eﬀects and may be expressed to
a greater level in male or female individuals, thereby making
more speciﬁc contributions when inherited from the mother
or father.
Besides inheritance, maternal and paternal environment
can aﬀect the development of asthma diﬀerently. Several
lines of evidence have indicated that factors present during
fetal development inﬂuence immune responses and allergen
sensitizationinearlylife.Duringpregnancy,thefetomaternal
interface is surrounded by Th2-prone environment [55],
which may suppress fetus-directed maternal Th1 immuneClinical and Developmental Immunology 5
responses [56]. This Th2 environment may be a good niche
for fetal allergy sensitization, because the Th2 cytokine mic-
roenvironment may prime T cells toward allergic diﬀerentia-
tion [57]. Maternal environmental factors, including mater-
nal prenatal exposure to tobacco smoke [58–62], household
allergens [63], traﬃc air pollution [64], and maternal occu-
pational exposure to latex and biocides [65], are associated
with childhood asthma; however, increasing maternal age,
maternal prenatal exposure to cat or dog [58, 66], maternal
ﬁsh intake [67], and maternal exposure to farming enviro-
nments [68] have been shown to exert protective eﬀects. One
study revealed that folic acid supplements during pregnancy
are associated with a slightly increased risk of wheezing and
lower respiratory tract infections up to 18 months of age
and suggests that methyl-group donors in the maternal diet
during pregnancy inﬂuence respiratory health in children
via epigenetic mechanisms [69]. Another study showed that
serum folate levels are inversely associated with total IgE
levels and that a dose-response relationship exists between
serum folate and outcomes of high total IgE level, atopy, and
wheezing [70]. However, a recent study does not support
the relationship between folic acid supplement and asthma
development [71]. In contrast, fewer paternal environmental
factors are associated with IgE production and asthma devel-
opment. It has been shown that paternal occupational ﬂour
dust exposure was associated with the development of
asthma [65]. These results indicate that environmental fac-
tors during pregnancy, directly or indirectly, play important
roles in allergic sensitization or disease development.
Environmental factors may inﬂuence gene expression,
cytokine secretion, T-cell diﬀerentiation, and the develop-
ment of allergic diseases via epigenetic mechanisms, possibly
by DNA methylation and histone modiﬁcation. In a study
using the Aspergillus fumigatus allergen murine model, chro-
nic inhalation of diesel exhaust particles induced hyperme-
thylation at the CpG-45, CpG-53, and CpG-205 sites of the
IFN-γ promoter in CD4 cells, and hypomethylation at CpG-
408 in the proximal IL-4 promoter in CD4 cells, both of
which signiﬁcantly correlated with higher IgE production
[74]. Perera and colleagues found that transplacental expo-
sure to traﬃc-related polycyclic aromatic hydrocarbons
(PAHs) is signiﬁcantly associated with hypermethylation of
acyl-CoA synthetase long-chain family member 3 (ACSL3)
[75], which may diminish fatty acid utilization and possibly
inﬂuence membrane phospholipid composition. Whether
these functional changes directly aﬀect the development of
the asthmatic phenotype is unknown and deserves further
investigation.
5. PaternalandMaternalInﬂuence on Gene-
Environment Interactions in Perinatal
IgE Productionand Childhood Asthma
IgE is produced by activated B cells, which interact with Th2
cells and undergo isotype class switching after the induction
of Th2 cell-derived cytokines, particularly IL-4 and IL-13.
Some lines of evidence indicate that IgE production in
children and adults is under strong genetic control [76, 77],
with heritability ranging from 60% to 87% in childhood.
We previously found that 21 SNPs in 14 allergy candidate
genes on chromosomes 4, 5, 6, 9, 10, 11, 12, 16, and 20 are
associated with elevated levels of CBIgE [78], a ﬁnding simi-
lar to ﬁndings of the studies on genetic association of serum
IgE and asthma [79, 80].
We have also previously shown the eﬀects of gene-gene
(IL13, rs20541 interaction between CCL17, rs223900, and
CXCL10, rs867562 on antenatal IgE production) and gene-
environment (maternal atopy alone and its interaction with
PIM1, GPIAP1, NOS2A, CTLA4, ADAM33, LTA, PDE2A,
GSR, IL13, FGF, CCL22, or CAT can aﬀect antenatal IgE
production) interactions on CBIgE production [78]. Ano-
ther study in Australia made a similar observation that
genetic variants in the Th2 pathways, particularly in the IL-
13, IL-13RA1, and STAT6 genes, are signiﬁcantly associated
withCBIgEconcentrationindividuallyandjointly.Thegene-
gene interaction and ethnic heterogeneity observed in that
study are similar to those observed in our study [93]. Both
studies indicate that genetic regulation of IgE production
begins in the prenatal stage and is inﬂuenced by diﬀerent
genetic backgrounds and maternal atopy status via gene-
environment interactions.
In IgE production and asthma, the maternal inﬂuence on
gene-environment interaction is more prominent than the
paternal inﬂuence is. Several studies have supported the
gender-dependentgene-environmentinteractionsonasthma
development, such as polymorphisms of CTLA-4 [26],
GSTM1 [94, 95], GSTP1 [96], IL-13 [97], IL-1Ra [98], βAR
[99], TGF-beta1 [100], HLA-G [101, 102], CD14 [103–106],
and TLR2 [107], may inﬂuence the development of asthma
through interactions with other maternal environmental
factors, such as maternal tobacco smoke exposure, maternal
atopy, or maternal prenatal exposure to a farming environ-
ment. Sensitization of the fetus due to interactions between
exclusive in utero maternal environmental factors and fetus
susceptible genes may be the most important reason why
maternal inﬂuence is greater than paternal inﬂuence during
fetal and infancy periods.
Multiple postnatal environmental factors have been pro-
ven to be associated with increased risk of childhood asthma.
As shown in Table 3, passive exposure to tobacco smoke in-
creases the risk of allergen sensitization [81] and childhood
rhinitis and asthma [60, 82–84], particularly when mothers
are not atopic. Children exposed to traﬃc exhaust have in-
creased risk of recurrent night cough and wheezing [85]a n d
allergen sensitization in children with speciﬁc genetic poly-
morphisms[64],whichmaybeassociatedwithIgE-mediated
asthma. In urban areas with high levels of vehicular traﬃc,
the most abundant components of air pollution are airborne
particulate matter, nitrogen dioxide, and ozone [86], which
may explain the increased prevalence of asthma or allergic
respiratory tract diseases in urban areas. Recent evidence has
also revealed that allergic sensitization is positively linked
to rhinovirus-related wheezing but not wheezing caused by
other viruses [89]. Early exposure to acetaminophen [90]
and broad-spectrum antibiotics [91] are also weakly associ-
ated withchildhood wheezing orasthma.On the otherhand,
breastfeeding [87, 88] and exposure to farming environment6 Clinical and Developmental Immunology
Table 3: Postnatal environmental factors associated with risk of childhood asthma.
Increased risk of childhood asthma Decreased risk of childhood asthma
Environmental tobacco smoke exposure [60, 81–84] Exposure to a farming environment [68]
Exposure to traﬃc exhaust and air pollution [64, 85, 86] Breastfeeding [87, 88]
Rhinovirus-related wheezing [89]
Early exposure to acetaminophen [90]
Broad spectrum antibiotics used in early childhood [91]
Early introduction of solid diet at infancy [67, 92]
and animals with increased levels of microbial substances
may protect against IgE-mediated allergic diseases [68]. A
report of two prospective birth cohorts on the association of
complementary foods with allergy stated that introduction
of solid foods with a high diversity of diﬀerent solids before
the end of the fourth month may increase the risk of later
allergy, particularly eczema. However, delayed introduction
ofsolidfoodsbeyondthesixthmonthofageortheavoidance
of allergenic foods during the ﬁrst year does not prevent
allergy development [67]. These ﬁndings are also reﬂected in
the new recommendation for allergy prevention published
by the American Academy of Pediatrics [108] and the Euro-
pean Society of Pediatric Gastroenterology, Hepatology and
Nutrition [109] .J o s e p ha n dh i sc o l l e a g u e sr e p o r t e dad i ﬀer-
ent ﬁnding that early introduction of complementary food
before the age of 4 months is associated with a reduced risk
of peanut (and perhaps egg) sensitization by the age of 2 to 3
years but only for children with a parental history of asthma
or allergy [92] .W h e t h e rp a t e r n a lo rm a t e r n a la t o p ya ﬀects
the postnatal environmental modulation of IgE production
and asthma development remains to be determined.
6. Conclusions
The development of immunity and allergen sensitization is
believed to start during the fetal period. CBIgE levels, reﬂect-
ing antenatal IgE production, is signiﬁcantly associated with
total IgE levels, allergen-speciﬁc IgE levels, and even occur-
renceofasthma,accordingtomoststudies.However,thesen-
sitivity and negative prediction rate are still unsatisfactory,
making it a poor predictor of childhood asthma. Postnatal
IgE, particularly after early childhood, is more sensitive and
more relevant to clinical applications in aiding the diagnosis
of IgE-medicated allergic diseases. The improvement of
CBIgE application methods for predicting allergic diseases
remains a big challenge.
Moststudieshaveshownthatbothpaternalandmaternal
factors have great impacts on IgE production and asthma
development in the oﬀspring. Genetic and environmental
factorsfrombothparentsalsocontributetothisimpact.This
literature review revealed that maternal inﬂuence begins in
thefetusandcontinuesthroughinfancy,childhood,andeven
adulthood, whereaspaternal eﬀectmay not be apparent until
early childhood, and the eﬀect may increase with increasing
age.
Asthma is a complex disease involving multiple genetic
backgrounds and multiple environmental insults. Some
speciﬁc genetic alleles may display greater eﬀect in speciﬁc
environments.Interactionsofmaternaloxidativestressgenes
(GSTM1,GSTP1,CAT,andMPO)withmaternalprenatalex-
p o s u r et oa i rp o l l u t a n t so rt o b a c c os m o k em a yc o n t r i b u t et o
asthma or allergic airway responsiveness. On the other hand,
interactions of TLR2, CD14 genotype, with farm exposure,
and/or endotoxin exposure may protect against the the de-
velopment of asthma. Experimental studies have revealed
that most environmental factors manifest their eﬀects on
asthma development through epigenetic mechanisms, such
as DNA methylation and histone modiﬁcation. An increase
in CpG methylation of the IFN-γ promoter and decrease in
CpG methylation of the IL-4 promoter have been observed
in response to chronic exposure to diesel exhaust [74], and
maternal prenatal exposure to PAHs has been linked to
hypermethylation of ACSL3 [75].Morestudiesarewarranted
to investigate the gene-environment interactions among
maternal inheritance, paternal inheritance, and environment
in perinatal stages for the prevention of IgE production and
asthma development.
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